光热治疗
巨噬细胞极化
癌症研究
材料科学
免疫原性细胞死亡
髓源性抑制细胞
氧化铁纳米粒子
癌细胞
肿瘤微环境
免疫疗法
癌症免疫疗法
癌症
免疫系统
巨噬细胞
纳米技术
化学
医学
免疫学
抑制器
纳米颗粒
肿瘤细胞
生物化学
体外
内科学
作者
Guang‐Tao Yu,Lang Rao,Hao Wu,Leilei Yang,Lin‐Lin Bu,Wei‐Wei Deng,Lei Wu,Xiaolin Nan,Wen‐Feng Zhang,Xingzhong Zhao,Wei Liu,Zhi‐Jun Sun
标识
DOI:10.1002/adfm.201801389
摘要
Abstract A major challenge for traditional cancer therapy, including surgical resection, chemoradiotherapy, and immunotherapy, is how to induce tumor cell death and leverage the host immune system at the same time. Here, a myeloid‐derived suppressor cell (MDSC) membrane‐coated iron oxide magnetic nanoparticle (MNP@MDSC) to overcome this conundrum for cancer therapy is developed. In this study, MNP@MDSC demonstrates its superior performance in immune evasion, active tumor‐targeting, magnetic resonance imaging, and photothermal therapy (PTT)‐induced tumor killing. Compared with red blood cell membrane‐coated nanoparticles (MNPs@RBC) or naked MNPs, MNP@MDSCs are much more effective in active tumor‐targeting, a beneficial property afforded by coating MNP with membranes from naturally occurring MDSC, thus converting the MNP into “smart” agents that like to accumulate in tumors as the source MDSCs. Once targeted to the tumor microenvironment, MNPs@MDSC can act as a PTT agents for enhanced antitumor response by inducing immunogenic cell death, reprogramming the tumor infiltrating macrophages, and reducing the tumor's metabolic activity. These benefits, in combination with the excellent biocompatibility and pharmacological kinetics characteristics, make MNP@MDSC a promising, multimodal agent for cancer theranostics.
科研通智能强力驱动
Strongly Powered by AbleSci AI